If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Open Access Modulatory effects of ZYM-201 sodium succinate on dietary-induced hyperlipidemic conditions

(PDF 442.6kb)
Download Article:


Sanguisorba officinalis, a well known and valuable medicinal plant in korea, china and japan has been used traditionally for the treatment of inflammatory and metabolic diseases such as diarrhea, chronic intestinal infections, duodenal ulcers, and bleeding. we studied the anti-hyperlipidemic effects of a chemically modified triterpenoid glycoside (zym-201 sodium succinate) isolated from sanguisorba officinalis in rats in which hyperlipidemia had been induced by dietary administration of cholesterol and cholic acid. oral administration of zym-201 sodium succinate (1 to 10 mg/kg) dose-dependently attenuated the diet-induced increases in body and liver weights. at 10 mg/kg, this compound also reversed the enhancement of serum levels of triglycerides (tg) and total cholesterol back to normal levels. in addition, imbalances in both serum and hepatic values of high-density lipoprotein (hdl), low-density lipoprotein (ldl), and very low-density lipoprotein (vldl) were prevented. finally, this compound both blocked the generation of lipid peroxide and hydroxyl radicals and enhanced the activity of superoxide dismutase (sod) in liver. therefore, our data strongly suggest that zym-201 sodium succinate could play a role in modulating hyperlipidemic conditions, which could be used as a valuable remedy for the treatment of relevant disorders such as atherosclerosis and vascular diseases.

Document Type: Research Article

DOI: http://dx.doi.org/10.1691/ph.2011.1512

Publication date: October 1, 2011

More about this publication?
  • Pharmazie is one of the world's leading pharmaceutical journals. As a peer-reviewed scientific journal, DiePharmazie is regularly indexed in Current Contents/Life Sciences, Excerpta Medica, Analytical Abstracts, International Pharmaceutical Abstracts, Beilstein Current Facts in Chemistry, Chemical Engineering and Biotechnology Abstracts (CEABA) and Science Citation Index.
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Terms & Conditions
  • ingentaconnect is not responsible for the content or availability of external websites
Related content



Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more